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It is of interest that the VSD signal recorded in response
to active contact is not so different from the response to
passive touch in anesthetized animals. Despite this sim-
ilarity, the response to active touch surely masks under-
lying neuronal dynamics that are absent in the case of
anesthesia. Neurons in vibrissa S1 cortex respond to
whisking motion in the absence of contact, a self-gener-
ated sensory signal, such that different neurons tend to
spike with higher probability at specific phases of the
whisk cycle. This encoding of movement is seen both
in extracellular (Fee et al., 1997) and intracellular record-
ings (Crochet and Petersen, 2006), yet was unresolved in
the present imaging study, most likely as a result of lim-
ited dynamic range of the detector. Another confound is
that reward modulates the degree of correlations among
neurons during a whisking task (Ganguly and Kleinfeld,
2004). Similarly, attention and possibly the contextual
nature of a task is likely to modulate the timing among
cortical spikes, as occurs in the somatosensory system
of primates (Steinmetz et al., 2000). Finally, active con-
tact incorporates the mechanics of the vibrissa and
the dynamics of the mystacial motor plant. The elastic
properties of the vibrissa (Hartmann et al., 2003; Nei-
mark et al., 2003) may lead to a multiplicity of stimulus-
induced spikes through mechanical resonances and
subsequent multiple contacts with an object. Multiple
or more intense contacts may also result from transient,
positive feedback in the brainstem sensorimotor loop
(Nguyen and Kleinfeld, 2005).
A general issue raised by the work of Ferezou et al.
is the interpretation of cortical responses in different be-
havioral states of the awake animal. It appears that the
widespread, large-amplitude, and long-duration electro-
physiological response evoked by passive stimulation
in the sessile mouse reflects a ‘‘startle mode’’ in which
animals are highly sensitive to unexpected sensory input
(Figure 1A). Behaviorally, one would expect that an unan-
ticipated stimulus delivered during the startle mode
should have a significant behavioral impact, i.e., animals
may become active in order to investigate the un-
expected stimulus. Ferezou et al. informally observed
such changes in that mice tended switch from sessile
to exploratory behaviors shortly after receiving passive
and unanticipated stimuli. In contrast, Ferezou et al.
did not observe any behavioral influence as a result of
passive stimulation during exploratory whisking, sug-
gestive of an ‘‘exploratory mode’’ in which the mouse
maintains a reliable expectation of sources of tactile
stimulation as it sweeps its vibrissae through space
(Figure 1B). One explanation is that unanticipated pas-
sive stimuli may be confused with self-motion, as op-
posed to contact with an object. Finally, Ferezou et al.
show that during these same periods of exploration,
physical contact of the vibrissae with an object leads to
a pronounced cortical response. This is suggestive of
an ‘‘object-detection mode’’ that provides information
about the location and identity of objects in the immedi-
ate environment that are of intense behavioral relevance
to the animal (Figure 1C).
A final issue concerns the implication of this study for
the interpretation of cortical response from anesthetized
animals. One the one hand, studies that define the topol-
ogy of afferents inputs, exemplified by recent maps of
direction sensitivity within individual columns in vibrissa
S1 cortex (Andermann and Moore, 2006), clearly depend
on the use of anesthesia to quench feedback connec-
tions. However, studies of cortical dynamics and feed-
back that make use of anesthetized animals may well
reach incorrect conclusions. The ascent of in vivo re-
cording from cortex of free-ranging behaving rodents
during vibrissa-based tasks (Fee et al., 1997; Krupa
et al., 2004) will further refine the relation between be-
havior and neural circuitry. Advances in in vivo imaging
technologies with free-ranging rodents, such as the
VSD technique utilized by Ferezou et al. and emerging
techniques that exploit nonlinear optics and endoge-
nous markers of neuronal activity (Helmchen and Denk,
2002), will further push these studies.
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Mutations in the PTEN-induced putative kinase 1
(PINK1) are a common cause of autosomal recessive
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527Parkinson’s disease. In a recent issue ofNature, two in-
dependent reports by Park et al. (2006) and Clark et al.
(2006) show that loss of Drosophila PINK1 leads to de-
fects in mitochondrial function resulting in male steril-
ity, apoptotic muscle degeneration, and minor loss of
dopamine neurons that is rescued by overexpression
of the ubiquitin E3 ligase, parkin. Thus, PINK1 and par-
kin appear to function in a common pathway suggest-
ing a convergence of the two genes most commonly
associated with autosomal recessive PD.
Parkinson’s disease (PD) is the most common neurode-
generative movement disorder characterized by age-de-
pendent increases in bradykinesia, muscular rigidity,
gait abnormalities, and a rest tremor (Moore et al.,
2005). The pathological hallmarks of PD include the
loss of dopaminergic (DA) neurons in the substantia ni-
gra pars compacta and the presence of ubiquitin-posi-
tive and a-synuclein-enriched inclusions designated
Lewy bodies. Current symptomatic therapy for PD pa-
tients revolves around the administration of L-Dopa. De-
velopment of preventative and better disease-modifying
therapies is dependent on understanding the pathogen-
esis of PD. The recent identification of PD-associated
genes has fueled much of the recent research in PD
where five genes are definitively linked to familial PD
(Moore et al., 2005). Three of these genes, parkin, DJ-1,
and PINK1, are associated with early-onset autosomal
recessive PD, in which a loss of function of a single
gene product results in the clinical manifestation of Par-
kinsonism (Table 1). Interestingly, all three autosomal re-
cessive-associated PD-related genes are somehow in-
volved in mitochondrial function (Figure 1). The more
common sporadic form of PD is also closely linked to mi-
tochondrial dysfunction, as environmental factors impli-
cated in PD cause reduced mitochondrial complex 1 ac-
tivity in animal models of PD (Abou-Sleiman et al., 2006).
Moreover, markers of oxidative stress and decrements
in mitochondrial complex 1 are observed in brains of
patients with sporadic PD. Both of the autosomal domi-
nant-associated genes, a-synuclein and leucine rich
repeat kinase 2 (LRRK2) may also play a role in mitochon-
drial function. Mice lacking the gene for the a-synuclein
are dramatically resistant to the mitochondrial toxin,
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(Dauer et al., 2002), and overexpression of a-synuclein
mutants leads to mitochondrial dysfunction both in vitro
and in vivo. LRRK2 is localized, in part, to the mitochon-
dria (West et al., 2005). Thus, accumulating evidence
suggests that mitochondrial dysfunction is central to
the mechanisms underlying the pathogenesis of PD.
In a recent issue of Nature Clark et al. (2006) and Park
et al. (2006) demonstrate the presence of a PINK1-parkin
pathway that regulates mitochondrial function. Bothgroups generated loss-of-function PINK1 mutant flies
through imprecise excision of the P element of PINK1.
For the most part, the phenotype of the PINK1 loss-of-
function mutant files was similar between groups. The
PINK1-deleted strains were viable, but the males were
completely sterile and most of the females were sterile.
Male sterility was due to spermatid mitochondria abnor-
malities as the mitochondria exhibited dramatic mor-
phologic changes with extensive vacuolation and swol-
len Nebenkern, a specialized mitochondrial derivative.
The flies exhibited a shorter life, age-dependent move-
ment disability, age-dependent increase of aberrant
wing phenotype, and disorganized muscle fibers result-
ing in poor flight performance, enlarged and abnormal
mitochondrial phenotype, and reduction in ATP levels.
Park et al. (2006) observed thoraces that were crushed
particularly in the midanterior and anterolateral regions
that were age-dependent and a small but significant
loss of DA neurons in the DM and DL regions. Clark
et al. (2006) showed that the loss-of-function PINK1 mu-
tants are sensitive to the free radical inducer, paraquat,
and the complex 1 inhibitor, rotenone, suggesting that
the absence of PINK1 leads to decreased resistance to
reactive oxygen species. PINK1 mutants were also
more sensitive to the protein folding inhibitor dithiothrei-
tol and osmotic stress, indicating that stress sensitivity
of PINK1 mutant was not limited to oxidative stress.
These phenotypes were all rescued by Drosophila
PINK1 expression and Clark et al. (2006) found that
some of the phenotypes were rescued by human
PINK1, suggesting that Drosophila and human PINK1
share at least some functional conservation.
There are several genetic model organisms for PD,
which includes models in mice, flies, worms, and yeast
(Dauer and Przedborski, 2003; Moore et al., 2005; Whit-
worth et al., 2006). Mouse and human biology are the
most similar, but recent mouse models, both genetic
and chemical, fail to fully recapitulate the pathogenesis
of PD with a striking lack of substantial phenotypes in
mouse models of autosomal recessive PD (Dauer and
Przedborski, 2003). In contrast, Drosophila models of
loss-of-function for parkin and PINK1 provide dramatic
phenotypes, with the caveat that the major abnormali-
ties primarily reside outside the nervous system. Both
parkin and PINK1 loss-of-function mutants have subtle
dopaminergic phenotypes similar to that observed for
loss-of-function Drosophila DJ-1 mutants. Why there
are only subtle phenotypes of direct relevance to PD in
both mouse and Drosophila models and why the more
dramaticDrosophila phenotypes are not observed in hu-
mans or mice with similar mutations remains a mystery.
All these models are at best presymptomatic models of
PD and suggest that in both mice and flies there is likely
to be compensatory mechanisms that render DA neu-
rons in these models relatively resistant to the toxicTable 1. Genetic Factors of Early-Onset Autosomal Recessive PD
Gene Function Percentage of Cases Locus Age of Onset
Parkin Ubiquitin E3 ligase >50% 6q25-27 <40
PINK1 Mitochondrial kinase 8-15% 1p35-36 18–51 years
DJ-1 Mitochondrial oxidative stress-response chaperone 1-2% 1p36 17–42 years
Putative function, percent of cases, loci, and age of onset of autosomal recessive inherited genes that cause Parkinson’s disease.
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ciated with Five Familial PD-Related Genes
Parkin functions to ubiquitinate substrate(s),
preventing their accumulation via the ubiqui-
tin proteasome system (UPS). Multiple cellu-
lar factors, such as nitrosylation (NO), reactive
oxidative stress (ROS), and BAG5, has been
shown to inhibit parkin E3 ligase function.
DJ-1 functions as a possible redox sensor or
as an antioxidant protein and acts to inhibit
a-synuclein aggregation, which impacts
both the UPS and mitochondria. Mitochon-
drial dysfunction can also contribute toa-syn-
uclein aggregation via ROS. Little is known
about LRRK2, a mixed-lineage kinase, though
it localizes, in part, to the outer mitochondria
membrane. PINK1 appears to act upstream
of parkin, where it may modulate the function
of parkin through unknown mechanisms.
Since PINK1’s kinase activity is impaired in fa-
milial PD-associated mutants, downstream
phosphorylation targets including parkin
might be key to understanding the role of
PINK1 and parkin in the pathogenesis of PD.effects of the mutation. Also, the short life span of Dro-
sophila and mice may prevent full manifestation of the
parkinsonian phenotype. Alternatively, these mutations
may require a second pathogenic hit to elicit DA neuron
degeneration. All three Drosophila loss-of-function mu-
tants for PINK1, parkin, and DJ-1 are more sensitive to
a variety of stressors, illustrating the potential impor-
tance of environmental and genetic interactions in the
pathogenesis of PD (Clark et al., 2006; Moore et al.,
2006; Park et al., 2006; Whitworth et al., 2006).
All the loss of PINK1 function phenotypes were highly
reminiscent of parkin mutants, and thus both groups
tested whether there were any possible interaction be-
tween the two genes. Both studies demonstrated dra-
matic restoration of all PINK1 loss-of-function pheno-
types by expression of parkin while overexpression of
PINK1 in the parkin loss-of-function mutants failed to
rescue the parkin mutants. Moreover, double mutants
removing both PINK1 and parkin function show identical
phenotypes, suggesting a linear relationship of the two
proteins. These results taken together suggest that
PINK1 and parkin function, at least in part, in the same
pathway in Drosophila, with PINK1 functioning up-
stream of parkin (Figure 1). How might PINK1 regulate
the function of parkin? Although recent results suggest
that phosphorylation of parkin inhibits its E3 ubiqutin li-
gase activity (Yamamoto et al., 2005), perhaps PINK1
phosphorylates parkin on an alternate residue activating
or maintaining it in a catalytically active state. In the ab-
sence of PINK1, parkin is no longer active, and thus it is
incapable of exerting its broad neuroprotective proper-
ties. Perhaps parkin regulates the steady-state level of
a protein critical for maintaining mitochondrial function.
Alternatively PINK1 could phosphorylate a previously
heretofore uncharacterized protein that is important
for the activation of parkin. Both of these scenarios
would require that PINK1 and Parkin exist in the same
subcellular compartment. Since PINK1’s mitochondrial
localization signal suggests that PINK1 should reside
within mitochondria, then parkin should reside there aswell. Although a very small fraction of parkin is associ-
ated with mitochondria, it does not appear to be an inte-
gral mitochondrial protein. Thus, if PINK1 and parkin
truly interact in a common pathway, then PINK1 may
have functions outside of the mitochondria, parkin re-
sides in the mitochondria, or there is an additional signal
between PINK1, the mitochondria, and parkin. Since
PINK1 overexpression does not rescue the parkin’s
loss-of-function phenotype, it is unlikely that parkin reg-
ulates the function of PINK1. Alternatively, one needs to
consider that parkin’s rescue of the PINK1’s loss-of-
function phenotype might be due to its broad protective
properties, much in the same way that overexpression
of Buffy, the sole Drosophila Bcl-2 homolog, reverses
the PINK1 loss-of-function mutant phenotype (Park
et al., 2006). How loss of PINK1 function leads to such
profound mitochondrial defects was not explored other
than that there seems to be ectopic activation of the JNK
pathway, as has been reported for parkin loss-of-func-
tion mutants (Cha et al., 2005). Future studies will need
to address all these issues.
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